Mai Osman Mohamed Kadry | Biochemistry | Best Researcher Award

Assist. Prof. Dr. Mai Osman Mohamed Kadry | Biochemistry | Best Researcher Award

Assist. Prof. Dr. Mai O.Kadry,National Research Center, Egypt

Dr. Mai Osman Mohamed Kadry is a distinguished biochemistry researcher at the Therapeutic Chemistry Department, National Research Centre, Egypt. With a Doctorate in Biochemistry from Cairo University (2016), her work focuses on oxidative injury, nanotoxicity, and cancer therapy. She has published extensively in high-impact journals on topics like antioxidant effects, stem cell therapies, and metabolic disorders. Dr. Kadry has also contributed to academia, teaching pharmacognosy at 6th October University. Skilled in advanced techniques like PCR, HPLC, and ELISA, she actively participates in groundbreaking nanobiotechnology research projects. Dr. Kadry is committed to advancing therapeutic strategies for critical diseases.ย ๐Ÿ“š๐Ÿงฌ

Profile

๐ŸŽ“ Education

Assist. Prof. Dr. Mai O. Kadry boasts a strong academic foundation in pharmaceutical sciences. She earned her Doctorate in Biochemistry from the Faculty of Pharmacy, Cairo University, in 2016, with a thesis on the โ€œAmelioration of Nano-Sized Titanium Dioxide-Induced Oxidative Injury in Mice by Some Antioxidants.โ€ She obtained her Masterโ€™s degree in Pharmaceutical Sciences from Helwan University in 2008, focusing on the synergistic effects of phytic and catechin on carbon tetrachloride-induced damage in rats. Dr. Kadry completed her B.Sc. in Pharmaceutical Science at Ain Shams University in 2003, graduating with honors. She also attended English language schools, enhancing her global communication skills.ย ๐ŸŒŸ๐Ÿ”ฌ

๐Ÿงช Experience

Assist. Prof. Dr. Mai O. Kadry has accumulated valuable experience in academia and research. She served as a pharmacognosy instructor at the Faculty of Pharmacy, 6th October University, Cairo, Egypt (2003โ€“2004), where she effectively delivered courses on natural products and their therapeutic applications. Dr. Kadry also contributed as a staff member focused on development and quality enhancement, aligning with the standards of the National Commission for Academic Accreditation. Her dedication to education and quality assurance reflects her commitment to fostering academic excellence and professional growth in pharmaceutical sciences.ย ๐Ÿ“š๐Ÿ”ฌ

Trainingย ๐Ÿงฌ๐Ÿ“š

Assist. Prof. Dr. Mai O. Kadry has undergone extensive training in various scientific disciplines. She completed courses in Biostatistics (November 2016) and Bioinformatics (January 2017) at the National Research Centre. Earlier, she gained expertise in Scientific Typewriting Bases (March 2007) and Occupational Health and Safety (June 2009). Additionally, she mastered Protein Electrophoresis through a four-month course in 2006. Dr. Kadry enhanced her practical skills with hands-on training at Al-Borg Clinical Laboratory, focusing on PCR techniques for detecting HBV and HCV at the Theodor Bilharz Research Institute. Her comprehensive training equips her with valuable laboratory and analytical skills.ย ๐Ÿ”ฌ๐Ÿงช

๐Ÿ”ฌ Research Focus

Assist. Prof. Dr. Mai O. Kadry focuses on cutting-edge biomedical research, emphasizing toxicity, cancer therapy, andย molecular biology. Her work explores inflammatory mediators, DNA damage, and therapeutic approaches in liver, brain, and nephrotoxicity contexts. She investigates autophagy, necroptosis, and novel strategies like resveratrol nano-formulations for ovarian cancer. Dr. Kadry also studies molecular pathways in gastric and prostate cancers, including miRNA-lncRNA signaling and CRISPR-Cas9 applications. Other interests involve genetic mutations in leukemia, drug-delivery systems, and nanotechnology for breast cancer. Her contributions bridge diagnostics, therapeutic innovations, and cellular mechanisms in oncology and toxicology.ย ๐Ÿ”ฌโœจ

โœ… Conclusion

Assist. Prof. Dr. Mai O. Kadry is a distinguished biochemistry researcher whose work bridges advanced molecular biology and therapeutic innovation. With expertise in nanotoxicity, oxidative injury, and cancer therapy, she contributes significantly to biomedical science through impactful research and academic leadership. Her training in cutting-edge techniques and her focus on translational medicine position her at the forefront of scientific discovery. Dr. Kadryโ€™s dedication to improving healthcare through targeted therapies and her commitment to academic excellence make her a valuable asset to the scientific community. Her career reflects passion, innovation, and a relentless pursuit of better treatment solutions.

 

Publications
  • Collaboration of Hprt/K-RAS/c-Myc mutation in the oncogenesis of T-lymphocytic leukemia: aย comparative study

    Future Science OA
    2024-12-31 |ย Journal article
    CONTRIBUTORS:ย Mai O Kadry;ย Abdel-Hamid Z Abdel Hamid;ย Rehab M Abdel-Megeed
  • Fischer’s oligopeptide ratio in ischemic hypoxia: prophylactic amendment of sophoretin and melatonin supplementation

    Future Science OA
    2024-12-31 |ย Journal article
    CONTRIBUTORS: Mai O Kadry; Hanaa Mahmoud Al
  • Thioctic acid shield against lipopolysaccharide depression and endoplasmic reticulum stress: GR7M/Homer/ATF6 signaling

    Future Science OA
    2024-12-31 |ย Journal article
    CONTRIBUTORS: Mai O. Kadry; Rehab M. Abdel-Megee

Elijah Stommel | Toxicology | Best Researcher Award

Dr. Elijah Stommel | Toxicology | Best Researcher Award

Dr. Elijah W. Stommel is a distinguished neurologist born in Hamilton, Bermuda ๐ŸŒŠ, currently serving as Professor of Neurology at the Geisel School of Medicine at Dartmouth ๐Ÿง , renowned for his clinical expertise, pioneering ALS research, and dedication to patient-centered care ๐Ÿ’ก; his prolific academic journey, consulting roles, and leadership in rare disease research reflect decades of unwavering service to neurology ๐Ÿฅ, academia ๐Ÿ“š, and public health advocacy ๐Ÿงฌ.

Profile

Education ๐ŸŽ“

Dr. Stommel holds an M.D. (1987) and a Ph.D. in Physiology (1984) from Boston University School of Medicine ๐ŸŽ“; he earned a B.A. with High Honors in Music from Bowdoin College ๐ŸŽต (1977), pursued advanced coursework at MIT ๐Ÿ›๏ธ, and honed his research skills as a Research Assistant at the Marine Biological Laboratory in Woods Hole ๐Ÿ”ฌ โ€” blending physiology, neurology, and music to form a truly interdisciplinary academic foundation ๐Ÿ“˜.

Experience ๐Ÿ‘จโ€๐Ÿซ

With over three decades in clinical neurology ๐Ÿง , Dr. Stommel progressed from Chief Resident at Dartmouth-Hitchcock (1990-91) to Professor of Neurology (2013โ€“present) ๐Ÿ‘จโ€๐Ÿซ; he has served as Staff Neurologist at Dartmouth-Hitchcock Clinic since 1991 ๐Ÿฅ, held multiple consultant roles across Vermont and New Hampshire ๐Ÿ—บ๏ธ, and co-directs the Electromyography Lab โšก, establishing himself as a trusted educator, clinician, and research mentor in both academic and hospital environments ๐ŸŒŸ.

Awards & Recognitions ๐Ÿ…

Dr. Stommelโ€™s commitment to humanism and excellence in neurology earned him a nomination for the prestigious Tow Humanism in Medicine Award ๐Ÿ† (2011); he is a Fellow of the American Academy of Neurology ๐ŸŽ–๏ธ and holds long-standing certifications in Electrodiagnostic Medicine and Neurology ๐Ÿง , complemented by leadership roles on numerous committees advancing research ethics, clinical trials, and medical education ๐Ÿ“‹๐Ÿ’ก.

Research Interests ๐Ÿ”ฌ

Dr. Stommelโ€™s research revolves around neurodegenerative diseases, especially ALS ๐Ÿงฌ, exploring environmental toxins ๐ŸŒฟ, nanotechnology ๐Ÿงช, and biomarkers ๐Ÿ” to advance diagnostics and therapeutics; as an active reviewer and editor for journals like Nature Nanotechnology, Frontiers in Neurology, and Molecular Neurobiology ๐Ÿง , he continually shapes scientific discourse while his collaborative work with global ALS consortia helps identify novel causal pathways and treatment avenues ๐ŸŒ๐Ÿ’ก.

Publications